ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009

Dec 24, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (ogxi)
CIK: 0000949858
Period of Report: 2009-12-22

Reporting Person: Brady Patrick Robert (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-22	Common Stock	M	5359	$2.69	Acquired	5359	Indirect
2009-12-22	Common Stock	M	11641	$2.69	Acquired	17000	Indirect
2009-12-22	Common Stock	M	4130	$7.25	Acquired	21130	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-12-22	Stock Option (Right to Buy0	$2.69	M	5359	Disposed	2010-03-23	Common Stock (5359)	Direct
2009-12-22	Stock Option (Right to Buy0	$2.69	M	11641	Disposed	2009-12-23	Common Stock (11641)	Direct
2009-12-22	Stock Option (Right to Buy0	$7.25	M	4130	Disposed	2010-03-23	Common Stock (4130)	Direct

Footnotes

F1: These shares were issued to Working Opportunity Fund (EVCC) Ltd. upon the exercise of a stock option held by Mr. Brady. Mr. Brady is a Vice-President of Growthworks Capital Ltd., an affiliate of Working Opportunity Fund (EVCC) Ltd.